货号:GS40327
Ifinatamab deruxtecan (I-DXd) is an investigational antibody-drug conjugate (ADC) targeting the B7-H3 protein, used in advanced cancers like small cell lung cancer (SCLC) and prostate cancer, showing promising response rates in Phase 2 trials, though it carries risks like fatigue, low blood counts, and lung issues, and is under development by Daiichi Sankyo & Merck.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯